New Delhi, July 26 (IANS) The Centre has taken several initiatives to expand the reach of Government e-Marketplace (GeM) among MSEs, startups and women entrepreneurs.
New Delhi, July 26 (IANS) Maharatna public sector company Steel Authority of India Limited (SAIL) has recorded a strong growth of 273 per cent in the Profit before Exceptional Items and Tax during the first quarter of the current financial year.
New Delhi, July 25 (IANS) The Atal Pension Yojana (APY) has achieved a significant milestone by surpassing 8 crore total gross enrollments with an addition of 39 lakh new subscribers in the current Financial Year (FY 2025-26) alone, the Ministry of Finance said on Friday.
New Delhi, July 25 (IANS) Covid-19 vaccination did not increase the risk of sudden deaths, Union Health Minister J.P. Nadda said in the Parliament on Friday.
New Delhi, July 25 (IANS) India is open to sharing its artificial intelligence (AI) models with Global South, IT Secretary S. Krishnan said on Friday.
Mumbai, July 25 (IANS) The Indian stock market closed in the negative territory on Friday, with the domestic stock indices declining by up to a per cent amid selling pressure.
New Delhi, July 25 (IANS) More than 9.84 crore hospital admissions worth over Rs. 1.40 lakh crore have been authorised under the flagship Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) scheme, the government informed the Parliament during the ongoing Monsoon Session on Friday.
New Delhi, July 25 (IANS) The recent imposition of export restrictions on key rare earth magnets has resulted in supply chain bottlenecks impacting the user industries, including auto and electronics sectors, but there are no reports about cost escalation or project delays from industries in Maharashtra, the Parliament was informed on Friday.
Mumbai, July 25 (IANS) The era of completely free digital transactions via the Unified Payments Interface (UPI) may not last forever, RBI Governor Sanjay Malhotra signalled on Friday, adding that the UPI interface should be made financially sustainable in the future.
New Delhi, July 25 (IANS) Hepatitis B drugs are being vastly underused, and boosting early treatment against the deadly hepatitis B virus (HBV) could save many lives over time, argued scientists in a new paper published in Lancet Gastroenterology and Hepatology.
